LEON Team to Attend CPHI Japan 2025 – Meet Us in Tokyo!

We’re excited to announce that the LEON team will be attending CPHI Japan 2025 in Tokyo from April 9–11.

Visit us at stand 5R-25 and explore our cutting-edge solutions:

  • Live Demonstration of NANOlab® – See our technology in action
  • Explore Our Innovative Solutions – Learn how we can support your needs
  • Discuss Future Collaboration Opportunities – Let’s build the future together

Schedule a meeting – Contact us in advance to set up a meeting and discuss how we can collaborate.

About LEON

Based in Planegg/Munich, leon-nanodrugs GmbH is a pharmatech company specializing in the development and commercialization of equipment for the encapsulation of genetic material and other pharmaceutical active substances into nanoparticles, such as lipid nanoparticles (LNPs).

The company leverages its proprietary FR-JET®  technology to build innovative solutions. Its equipment portfolio includes NANOscreen® for formulation screening, NANOlab® for process development, as well as NANOme® and NANOus® for GMP manufacture. These systems are suitable for both individualized scales and commercial production, and the company further supports its clients by offering formulation and process development services.

LEON’s platform aims to empower pharmaceutical companies, small biotech, research institutes, and CDMOs to capitalize on advancements in advanced therapies.

For general information and enquiries please email info@leon-nanodrugs.com